Safety Study of Ch-mAb7F9 for Methamphetamine Abuse

NCT01603147 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

InterveXion Therapeutics, LLC

Collaborators